Literature DB >> 12467246

Toll-like receptor-5 and the innate immune response to bacterial flagellin.

K D Smith1, A Ozinsky.   

Abstract

The innate immune system identifies the presence of infection by detecting structures that are unique to microbes and that are not expressed in the host. The bacterial flagellum (Latin, a whip) confers motility, on a wide range of bacterial species. Vertebrates, plants, and invertebrates all have evolved flagellar recognition systems that are activated by flagellin, the major component of the bacterial flagellar filament. In mammals, flagellin is recognized by Toll-like receptor-5 and activates defense responses both systemically and at epithelial surfaces. Here, we review the role for Toll-like receptor-5 in mediating the mammalian innate immune response to flagellin, and how this provides for defense against infections caused by many different species of flagellated bacteria.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12467246     DOI: 10.1007/978-3-642-59430-4_6

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  19 in total

1.  Pseudomonas aeruginosa evasion of phagocytosis is mediated by loss of swimming motility and is independent of flagellum expression.

Authors:  Eyal Amiel; Rustin R Lovewell; George A O'Toole; Deborah A Hogan; Brent Berwin
Journal:  Infect Immun       Date:  2010-05-10       Impact factor: 3.441

Review 2.  How flagellin and toll-like receptor 5 contribute to enteric infection.

Authors:  Theodore S Steiner
Journal:  Infect Immun       Date:  2006-11-21       Impact factor: 3.441

Review 3.  The FliK protein and flagellar hook-length control.

Authors:  Richard C Waters; Paul W O'Toole; Kieran A Ryan
Journal:  Protein Sci       Date:  2007-05       Impact factor: 6.725

4.  Flagellin/TLR5 responses in epithelia reveal intertwined activation of inflammatory and apoptotic pathways.

Authors:  Hui Zeng; Huixia Wu; Valerie Sloane; Rheinallt Jones; Yimin Yu; Patricia Lin; Andrew T Gewirtz; Andrew S Neish
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2005-09-22       Impact factor: 4.052

5.  Toll-like receptors and CD40 modulate each other's expression affecting Leishmania major infection.

Authors:  H S Chandel; S P Pandey; D Shukla; K Lalsare; S K Selvaraj; M K Jha; B Saha
Journal:  Clin Exp Immunol       Date:  2014-05       Impact factor: 4.330

6.  CD4+ T cells and toll-like receptors recognize Salmonella antigens expressed in bacterial surface organelles.

Authors:  Molly A Bergman; Lisa A Cummings; Sara L Rassoulian Barrett; Kelly D Smith; J Cano Lara; Alan Aderem; Brad T Cookson
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

7.  The p110α and p110β isoforms of class I phosphatidylinositol 3-kinase are involved in toll-like receptor 5 signaling in epithelial cells.

Authors:  Sabine M Ivison; Mohammed A S Khan; Nicholas R Graham; Leila A Shobab; Yu Yao; Arnawaz Kifayet; Laura M Sly; Theodore S Steiner
Journal:  Mediators Inflamm       Date:  2010-10-03       Impact factor: 4.711

8.  Incorporation of membrane-anchored flagellin into influenza virus-like particles enhances the breadth of immune responses.

Authors:  Bao-Zhong Wang; Fu-Shi Quan; Sang-Moo Kang; Jadranka Bozja; Ioanna Skountzou; Richard W Compans
Journal:  J Virol       Date:  2008-09-10       Impact factor: 5.103

9.  Enteroaggregative Escherichia coli flagellin-induced interleukin-8 secretion requires Toll-like receptor 5-dependent p38 MAP kinase activation.

Authors:  Mohammed A S Khan; Jian Kang; Theodore S Steiner
Journal:  Immunology       Date:  2004-08       Impact factor: 7.397

10.  Campylobacter-induced interleukin-8 secretion in polarized human intestinal epithelial cells requires Campylobacter-secreted cytolethal distending toxin- and Toll-like receptor-mediated activation of NF-kappaB.

Authors:  Jie Zheng; Jianghong Meng; Shaohua Zhao; Ruby Singh; Wenxia Song
Journal:  Infect Immun       Date:  2008-07-21       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.